nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefpodoxime—Pneumonia—Etoposide—germ cell cancer	0.00283	0.00283	CcSEcCtD
Cefpodoxime—Aplastic anaemia—Methotrexate—germ cell cancer	0.00282	0.00282	CcSEcCtD
Cefpodoxime—Paraesthesia—Vinblastine—germ cell cancer	0.00282	0.00282	CcSEcCtD
Cefpodoxime—Alopecia—Ifosfamide—germ cell cancer	0.00282	0.00282	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Dactinomycin—germ cell cancer	0.00282	0.00282	CcSEcCtD
Cefpodoxime—Anaemia—Dactinomycin—germ cell cancer	0.0028	0.0028	CcSEcCtD
Cefpodoxime—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.00279	0.00279	CcSEcCtD
Cefpodoxime—Chest pain—Bleomycin—germ cell cancer	0.00277	0.00277	CcSEcCtD
Cefpodoxime—Myalgia—Bleomycin—germ cell cancer	0.00277	0.00277	CcSEcCtD
Cefpodoxime—Renal failure—Etoposide—germ cell cancer	0.00276	0.00276	CcSEcCtD
Cefpodoxime—Stomatitis—Etoposide—germ cell cancer	0.00274	0.00274	CcSEcCtD
Cefpodoxime—Discomfort—Bleomycin—germ cell cancer	0.00274	0.00274	CcSEcCtD
Cefpodoxime—Malaise—Dactinomycin—germ cell cancer	0.00274	0.00274	CcSEcCtD
Cefpodoxime—Decreased appetite—Vinblastine—germ cell cancer	0.00273	0.00273	CcSEcCtD
Cefpodoxime—Mouth ulceration—Methotrexate—germ cell cancer	0.00272	0.00272	CcSEcCtD
Cefpodoxime—Leukopenia—Dactinomycin—germ cell cancer	0.00272	0.00272	CcSEcCtD
Cefpodoxime—Pain—Vinblastine—germ cell cancer	0.00269	0.00269	CcSEcCtD
Cefpodoxime—Constipation—Vinblastine—germ cell cancer	0.00269	0.00269	CcSEcCtD
Cefpodoxime—Confusional state—Bleomycin—germ cell cancer	0.00268	0.00268	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Bleomycin—germ cell cancer	0.00266	0.00266	CcSEcCtD
Cefpodoxime—Agranulocytosis—Etoposide—germ cell cancer	0.00262	0.00262	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Bleomycin—germ cell cancer	0.0026	0.0026	CcSEcCtD
Cefpodoxime—Feeling abnormal—Vinblastine—germ cell cancer	0.00259	0.00259	CcSEcCtD
Cefpodoxime—Myalgia—Dactinomycin—germ cell cancer	0.00258	0.00258	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Ifosfamide—germ cell cancer	0.00258	0.00258	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00257	0.00257	CcSEcCtD
Cefpodoxime—Anaemia—Ifosfamide—germ cell cancer	0.00257	0.00257	CcSEcCtD
Cefpodoxime—Tinnitus—Cisplatin—germ cell cancer	0.00257	0.00257	CcSEcCtD
Cefpodoxime—Agitation—Ifosfamide—germ cell cancer	0.00256	0.00256	CcSEcCtD
Cefpodoxime—Discomfort—Dactinomycin—germ cell cancer	0.00255	0.00255	CcSEcCtD
Cefpodoxime—Anorexia—Bleomycin—germ cell cancer	0.00253	0.00253	CcSEcCtD
Cefpodoxime—Malaise—Ifosfamide—germ cell cancer	0.00251	0.00251	CcSEcCtD
Cefpodoxime—Vertigo—Ifosfamide—germ cell cancer	0.0025	0.0025	CcSEcCtD
Cefpodoxime—Leukopenia—Ifosfamide—germ cell cancer	0.00249	0.00249	CcSEcCtD
Cefpodoxime—Abdominal pain—Vinblastine—germ cell cancer	0.00249	0.00249	CcSEcCtD
Cefpodoxime—Hypotension—Bleomycin—germ cell cancer	0.00248	0.00248	CcSEcCtD
Cefpodoxime—Palpitations—Ifosfamide—germ cell cancer	0.00246	0.00246	CcSEcCtD
Cefpodoxime—Alopecia—Cisplatin—germ cell cancer	0.00243	0.00243	CcSEcCtD
Cefpodoxime—Cough—Ifosfamide—germ cell cancer	0.00243	0.00243	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Dactinomycin—germ cell cancer	0.00242	0.00242	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00242	0.00242	CcSEcCtD
Cefpodoxime—Convulsion—Ifosfamide—germ cell cancer	0.00241	0.00241	CcSEcCtD
Cefpodoxime—Hypertension—Ifosfamide—germ cell cancer	0.0024	0.0024	CcSEcCtD
Cefpodoxime—Erythema multiforme—Etoposide—germ cell cancer	0.00239	0.00239	CcSEcCtD
Cefpodoxime—Paraesthesia—Bleomycin—germ cell cancer	0.00238	0.00238	CcSEcCtD
Cefpodoxime—Dyspnoea—Bleomycin—germ cell cancer	0.00237	0.00237	CcSEcCtD
Cefpodoxime—Chest pain—Ifosfamide—germ cell cancer	0.00237	0.00237	CcSEcCtD
Cefpodoxime—Myalgia—Ifosfamide—germ cell cancer	0.00237	0.00237	CcSEcCtD
Cefpodoxime—Flatulence—Cisplatin—germ cell cancer	0.00236	0.00236	CcSEcCtD
Cefpodoxime—Anorexia—Dactinomycin—germ cell cancer	0.00236	0.00236	CcSEcCtD
Cefpodoxime—Discomfort—Ifosfamide—germ cell cancer	0.00234	0.00234	CcSEcCtD
Cefpodoxime—Hypersensitivity—Vinblastine—germ cell cancer	0.00232	0.00232	CcSEcCtD
Cefpodoxime—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.00231	0.00231	CcSEcCtD
Cefpodoxime—Decreased appetite—Bleomycin—germ cell cancer	0.00231	0.00231	CcSEcCtD
Cefpodoxime—Confusional state—Ifosfamide—germ cell cancer	0.00229	0.00229	CcSEcCtD
Cefpodoxime—Pain—Bleomycin—germ cell cancer	0.00227	0.00227	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00227	0.00227	CcSEcCtD
Cefpodoxime—Chills—Etoposide—germ cell cancer	0.00226	0.00226	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00226	0.00226	CcSEcCtD
Cefpodoxime—Asthenia—Vinblastine—germ cell cancer	0.00226	0.00226	CcSEcCtD
Cefpodoxime—Tremor—Cisplatin—germ cell cancer	0.00225	0.00225	CcSEcCtD
Cefpodoxime—Alopecia—Etoposide—germ cell cancer	0.00223	0.00223	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Cisplatin—germ cell cancer	0.00222	0.00222	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00222	0.00222	CcSEcCtD
Cefpodoxime—Anaemia—Cisplatin—germ cell cancer	0.00222	0.00222	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00219	0.00219	CcSEcCtD
Cefpodoxime—Feeling abnormal—Bleomycin—germ cell cancer	0.00219	0.00219	CcSEcCtD
Cefpodoxime—Anorexia—Ifosfamide—germ cell cancer	0.00216	0.00216	CcSEcCtD
Cefpodoxime—Malaise—Cisplatin—germ cell cancer	0.00216	0.00216	CcSEcCtD
Cefpodoxime—Decreased appetite—Dactinomycin—germ cell cancer	0.00215	0.00215	CcSEcCtD
Cefpodoxime—Diarrhoea—Vinblastine—germ cell cancer	0.00215	0.00215	CcSEcCtD
Cefpodoxime—Dysgeusia—Etoposide—germ cell cancer	0.00215	0.00215	CcSEcCtD
Cefpodoxime—Leukopenia—Cisplatin—germ cell cancer	0.00215	0.00215	CcSEcCtD
Cefpodoxime—Fatigue—Dactinomycin—germ cell cancer	0.00213	0.00213	CcSEcCtD
Cefpodoxime—Back pain—Etoposide—germ cell cancer	0.00212	0.00212	CcSEcCtD
Cefpodoxime—Hypotension—Ifosfamide—germ cell cancer	0.00212	0.00212	CcSEcCtD
Cefpodoxime—Pain—Dactinomycin—germ cell cancer	0.00212	0.00212	CcSEcCtD
Cefpodoxime—Urticaria—Bleomycin—germ cell cancer	0.00211	0.00211	CcSEcCtD
Cefpodoxime—Body temperature increased—Bleomycin—germ cell cancer	0.0021	0.0021	CcSEcCtD
Cefpodoxime—Dizziness—Vinblastine—germ cell cancer	0.00208	0.00208	CcSEcCtD
Cefpodoxime—Convulsion—Cisplatin—germ cell cancer	0.00208	0.00208	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00207	0.00207	CcSEcCtD
Cefpodoxime—Myalgia—Cisplatin—germ cell cancer	0.00204	0.00204	CcSEcCtD
Cefpodoxime—Feeling abnormal—Dactinomycin—germ cell cancer	0.00204	0.00204	CcSEcCtD
Cefpodoxime—Paraesthesia—Ifosfamide—germ cell cancer	0.00204	0.00204	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Etoposide—germ cell cancer	0.00204	0.00204	CcSEcCtD
Cefpodoxime—Anxiety—Cisplatin—germ cell cancer	0.00203	0.00203	CcSEcCtD
Cefpodoxime—Anaemia—Etoposide—germ cell cancer	0.00203	0.00203	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00202	0.00202	CcSEcCtD
Cefpodoxime—Dyspnoea—Ifosfamide—germ cell cancer	0.00202	0.00202	CcSEcCtD
Cefpodoxime—Somnolence—Ifosfamide—germ cell cancer	0.00202	0.00202	CcSEcCtD
Cefpodoxime—Discomfort—Cisplatin—germ cell cancer	0.00202	0.00202	CcSEcCtD
Cefpodoxime—Vomiting—Vinblastine—germ cell cancer	0.002	0.002	CcSEcCtD
Cefpodoxime—Malaise—Etoposide—germ cell cancer	0.00198	0.00198	CcSEcCtD
Cefpodoxime—Vertigo—Etoposide—germ cell cancer	0.00197	0.00197	CcSEcCtD
Cefpodoxime—Decreased appetite—Ifosfamide—germ cell cancer	0.00197	0.00197	CcSEcCtD
Cefpodoxime—Headache—Vinblastine—germ cell cancer	0.00197	0.00197	CcSEcCtD
Cefpodoxime—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.00197	0.00197	CcSEcCtD
Cefpodoxime—Leukopenia—Etoposide—germ cell cancer	0.00197	0.00197	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00196	0.00196	CcSEcCtD
Cefpodoxime—Abdominal pain—Dactinomycin—germ cell cancer	0.00196	0.00196	CcSEcCtD
Cefpodoxime—Body temperature increased—Dactinomycin—germ cell cancer	0.00196	0.00196	CcSEcCtD
Cefpodoxime—Fatigue—Ifosfamide—germ cell cancer	0.00196	0.00196	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Cisplatin—germ cell cancer	0.00196	0.00196	CcSEcCtD
Cefpodoxime—Hypersensitivity—Bleomycin—germ cell cancer	0.00196	0.00196	CcSEcCtD
Cefpodoxime—Pain—Ifosfamide—germ cell cancer	0.00194	0.00194	CcSEcCtD
Cefpodoxime—Constipation—Ifosfamide—germ cell cancer	0.00194	0.00194	CcSEcCtD
Cefpodoxime—Loss of consciousness—Etoposide—germ cell cancer	0.00193	0.00193	CcSEcCtD
Cefpodoxime—Cough—Etoposide—germ cell cancer	0.00192	0.00192	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Cisplatin—germ cell cancer	0.00192	0.00192	CcSEcCtD
Cefpodoxime—Asthenia—Bleomycin—germ cell cancer	0.0019	0.0019	CcSEcCtD
Cefpodoxime—Convulsion—Etoposide—germ cell cancer	0.0019	0.0019	CcSEcCtD
Cefpodoxime—Hypertension—Etoposide—germ cell cancer	0.0019	0.0019	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Cisplatin—germ cell cancer	0.00189	0.00189	CcSEcCtD
Cefpodoxime—Asthma—Methotrexate—germ cell cancer	0.00189	0.00189	CcSEcCtD
Cefpodoxime—Pruritus—Bleomycin—germ cell cancer	0.00188	0.00188	CcSEcCtD
Cefpodoxime—Feeling abnormal—Ifosfamide—germ cell cancer	0.00187	0.00187	CcSEcCtD
Cefpodoxime—Chest pain—Etoposide—germ cell cancer	0.00187	0.00187	CcSEcCtD
Cefpodoxime—Eosinophilia—Methotrexate—germ cell cancer	0.00187	0.00187	CcSEcCtD
Cefpodoxime—Nausea—Vinblastine—germ cell cancer	0.00187	0.00187	CcSEcCtD
Cefpodoxime—Anorexia—Cisplatin—germ cell cancer	0.00186	0.00186	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00186	0.00186	CcSEcCtD
Cefpodoxime—Discomfort—Etoposide—germ cell cancer	0.00185	0.00185	CcSEcCtD
Cefpodoxime—Hypotension—Cisplatin—germ cell cancer	0.00183	0.00183	CcSEcCtD
Cefpodoxime—Hypersensitivity—Dactinomycin—germ cell cancer	0.00182	0.00182	CcSEcCtD
Cefpodoxime—Confusional state—Etoposide—germ cell cancer	0.00181	0.00181	CcSEcCtD
Cefpodoxime—Urticaria—Ifosfamide—germ cell cancer	0.0018	0.0018	CcSEcCtD
Cefpodoxime—Abdominal pain—Ifosfamide—germ cell cancer	0.00179	0.00179	CcSEcCtD
Cefpodoxime—Body temperature increased—Ifosfamide—germ cell cancer	0.00179	0.00179	CcSEcCtD
Cefpodoxime—Pancytopenia—Methotrexate—germ cell cancer	0.00179	0.00179	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Etoposide—germ cell cancer	0.00179	0.00179	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00178	0.00178	CcSEcCtD
Cefpodoxime—Asthenia—Dactinomycin—germ cell cancer	0.00178	0.00178	CcSEcCtD
Cefpodoxime—Dysuria—Methotrexate—germ cell cancer	0.00177	0.00177	CcSEcCtD
Cefpodoxime—Neutropenia—Methotrexate—germ cell cancer	0.00177	0.00177	CcSEcCtD
Cefpodoxime—Paraesthesia—Cisplatin—germ cell cancer	0.00176	0.00176	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Etoposide—germ cell cancer	0.00175	0.00175	CcSEcCtD
Cefpodoxime—Dyspnoea—Cisplatin—germ cell cancer	0.00174	0.00174	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Etoposide—germ cell cancer	0.00173	0.00173	CcSEcCtD
Cefpodoxime—Photosensitivity reaction—Methotrexate—germ cell cancer	0.00172	0.00172	CcSEcCtD
Cefpodoxime—Anorexia—Etoposide—germ cell cancer	0.00171	0.00171	CcSEcCtD
Cefpodoxime—Decreased appetite—Cisplatin—germ cell cancer	0.0017	0.0017	CcSEcCtD
Cefpodoxime—Diarrhoea—Dactinomycin—germ cell cancer	0.00169	0.00169	CcSEcCtD
Cefpodoxime—Pneumonia—Methotrexate—germ cell cancer	0.00169	0.00169	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00169	0.00169	CcSEcCtD
Cefpodoxime—Vomiting—Bleomycin—germ cell cancer	0.00169	0.00169	CcSEcCtD
Cefpodoxime—Hypotension—Etoposide—germ cell cancer	0.00167	0.00167	CcSEcCtD
Cefpodoxime—Rash—Bleomycin—germ cell cancer	0.00167	0.00167	CcSEcCtD
Cefpodoxime—Pain—Cisplatin—germ cell cancer	0.00167	0.00167	CcSEcCtD
Cefpodoxime—Dermatitis—Bleomycin—germ cell cancer	0.00167	0.00167	CcSEcCtD
Cefpodoxime—Hypersensitivity—Ifosfamide—germ cell cancer	0.00167	0.00167	CcSEcCtD
Cefpodoxime—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.00167	0.00167	CcSEcCtD
Cefpodoxime—Renal failure—Methotrexate—germ cell cancer	0.00165	0.00165	CcSEcCtD
Cefpodoxime—Stomatitis—Methotrexate—germ cell cancer	0.00164	0.00164	CcSEcCtD
Cefpodoxime—Asthenia—Ifosfamide—germ cell cancer	0.00163	0.00163	CcSEcCtD
Cefpodoxime—Feeling abnormal—Cisplatin—germ cell cancer	0.00161	0.00161	CcSEcCtD
Cefpodoxime—Paraesthesia—Etoposide—germ cell cancer	0.00161	0.00161	CcSEcCtD
Cefpodoxime—Pruritus—Ifosfamide—germ cell cancer	0.00161	0.00161	CcSEcCtD
Cefpodoxime—Haematuria—Methotrexate—germ cell cancer	0.0016	0.0016	CcSEcCtD
Cefpodoxime—Dyspnoea—Etoposide—germ cell cancer	0.0016	0.0016	CcSEcCtD
Cefpodoxime—Somnolence—Etoposide—germ cell cancer	0.00159	0.00159	CcSEcCtD
Cefpodoxime—Epistaxis—Methotrexate—germ cell cancer	0.00159	0.00159	CcSEcCtD
Cefpodoxime—Nausea—Bleomycin—germ cell cancer	0.00158	0.00158	CcSEcCtD
Cefpodoxime—Vomiting—Dactinomycin—germ cell cancer	0.00157	0.00157	CcSEcCtD
Cefpodoxime—Agranulocytosis—Methotrexate—germ cell cancer	0.00157	0.00157	CcSEcCtD
Cefpodoxime—Rash—Dactinomycin—germ cell cancer	0.00156	0.00156	CcSEcCtD
Cefpodoxime—Decreased appetite—Etoposide—germ cell cancer	0.00156	0.00156	CcSEcCtD
Cefpodoxime—Diarrhoea—Ifosfamide—germ cell cancer	0.00155	0.00155	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00155	0.00155	CcSEcCtD
Cefpodoxime—Body temperature increased—Cisplatin—germ cell cancer	0.00155	0.00155	CcSEcCtD
Cefpodoxime—Fatigue—Etoposide—germ cell cancer	0.00155	0.00155	CcSEcCtD
Cefpodoxime—Pain—Etoposide—germ cell cancer	0.00153	0.00153	CcSEcCtD
Cefpodoxime—Constipation—Etoposide—germ cell cancer	0.00153	0.00153	CcSEcCtD
Cefpodoxime—Haemoglobin—Methotrexate—germ cell cancer	0.00152	0.00152	CcSEcCtD
Cefpodoxime—Haemorrhage—Methotrexate—germ cell cancer	0.00151	0.00151	CcSEcCtD
Cefpodoxime—Dizziness—Ifosfamide—germ cell cancer	0.0015	0.0015	CcSEcCtD
Cefpodoxime—Feeling abnormal—Etoposide—germ cell cancer	0.00148	0.00148	CcSEcCtD
Cefpodoxime—Nausea—Dactinomycin—germ cell cancer	0.00147	0.00147	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Etoposide—germ cell cancer	0.00147	0.00147	CcSEcCtD
Cefpodoxime—Vomiting—Ifosfamide—germ cell cancer	0.00144	0.00144	CcSEcCtD
Cefpodoxime—Hypersensitivity—Cisplatin—germ cell cancer	0.00144	0.00144	CcSEcCtD
Cefpodoxime—Rash—Ifosfamide—germ cell cancer	0.00143	0.00143	CcSEcCtD
Cefpodoxime—Dermatitis—Ifosfamide—germ cell cancer	0.00143	0.00143	CcSEcCtD
Cefpodoxime—Erythema multiforme—Methotrexate—germ cell cancer	0.00143	0.00143	CcSEcCtD
Cefpodoxime—Urticaria—Etoposide—germ cell cancer	0.00142	0.00142	CcSEcCtD
Cefpodoxime—Body temperature increased—Etoposide—germ cell cancer	0.00142	0.00142	CcSEcCtD
Cefpodoxime—Abdominal pain—Etoposide—germ cell cancer	0.00142	0.00142	CcSEcCtD
Cefpodoxime—Tinnitus—Methotrexate—germ cell cancer	0.00141	0.00141	CcSEcCtD
Cefpodoxime—Asthenia—Cisplatin—germ cell cancer	0.0014	0.0014	CcSEcCtD
Cefpodoxime—Chills—Methotrexate—germ cell cancer	0.00136	0.00136	CcSEcCtD
Cefpodoxime—Nausea—Ifosfamide—germ cell cancer	0.00135	0.00135	CcSEcCtD
Cefpodoxime—Diarrhoea—Cisplatin—germ cell cancer	0.00134	0.00134	CcSEcCtD
Cefpodoxime—Alopecia—Methotrexate—germ cell cancer	0.00134	0.00134	CcSEcCtD
Cefpodoxime—Hypersensitivity—Etoposide—germ cell cancer	0.00132	0.00132	CcSEcCtD
Cefpodoxime—Dysgeusia—Methotrexate—germ cell cancer	0.00129	0.00129	CcSEcCtD
Cefpodoxime—Asthenia—Etoposide—germ cell cancer	0.00129	0.00129	CcSEcCtD
Cefpodoxime—Back pain—Methotrexate—germ cell cancer	0.00127	0.00127	CcSEcCtD
Cefpodoxime—Pruritus—Etoposide—germ cell cancer	0.00127	0.00127	CcSEcCtD
Cefpodoxime—Vomiting—Cisplatin—germ cell cancer	0.00124	0.00124	CcSEcCtD
Cefpodoxime—Rash—Cisplatin—germ cell cancer	0.00123	0.00123	CcSEcCtD
Cefpodoxime—Dermatitis—Cisplatin—germ cell cancer	0.00123	0.00123	CcSEcCtD
Cefpodoxime—Diarrhoea—Etoposide—germ cell cancer	0.00123	0.00123	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Methotrexate—germ cell cancer	0.00122	0.00122	CcSEcCtD
Cefpodoxime—Anaemia—Methotrexate—germ cell cancer	0.00122	0.00122	CcSEcCtD
Cefpodoxime—Malaise—Methotrexate—germ cell cancer	0.00119	0.00119	CcSEcCtD
Cefpodoxime—Dizziness—Etoposide—germ cell cancer	0.00119	0.00119	CcSEcCtD
Cefpodoxime—Vertigo—Methotrexate—germ cell cancer	0.00118	0.00118	CcSEcCtD
Cefpodoxime—Leukopenia—Methotrexate—germ cell cancer	0.00118	0.00118	CcSEcCtD
Cefpodoxime—Nausea—Cisplatin—germ cell cancer	0.00116	0.00116	CcSEcCtD
Cefpodoxime—Cough—Methotrexate—germ cell cancer	0.00115	0.00115	CcSEcCtD
Cefpodoxime—Convulsion—Methotrexate—germ cell cancer	0.00114	0.00114	CcSEcCtD
Cefpodoxime—Vomiting—Etoposide—germ cell cancer	0.00114	0.00114	CcSEcCtD
Cefpodoxime—Rash—Etoposide—germ cell cancer	0.00113	0.00113	CcSEcCtD
Cefpodoxime—Dermatitis—Etoposide—germ cell cancer	0.00113	0.00113	CcSEcCtD
Cefpodoxime—Headache—Etoposide—germ cell cancer	0.00112	0.00112	CcSEcCtD
Cefpodoxime—Chest pain—Methotrexate—germ cell cancer	0.00112	0.00112	CcSEcCtD
Cefpodoxime—Myalgia—Methotrexate—germ cell cancer	0.00112	0.00112	CcSEcCtD
Cefpodoxime—Discomfort—Methotrexate—germ cell cancer	0.00111	0.00111	CcSEcCtD
Cefpodoxime—Confusional state—Methotrexate—germ cell cancer	0.00108	0.00108	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Methotrexate—germ cell cancer	0.00107	0.00107	CcSEcCtD
Cefpodoxime—Nausea—Etoposide—germ cell cancer	0.00106	0.00106	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Methotrexate—germ cell cancer	0.00105	0.00105	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Methotrexate—germ cell cancer	0.00104	0.00104	CcSEcCtD
Cefpodoxime—Anorexia—Methotrexate—germ cell cancer	0.00102	0.00102	CcSEcCtD
Cefpodoxime—Hypotension—Methotrexate—germ cell cancer	0.001	0.001	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000978	0.000978	CcSEcCtD
Cefpodoxime—Insomnia—Methotrexate—germ cell cancer	0.000971	0.000971	CcSEcCtD
Cefpodoxime—Paraesthesia—Methotrexate—germ cell cancer	0.000964	0.000964	CcSEcCtD
Cefpodoxime—Dyspnoea—Methotrexate—germ cell cancer	0.000957	0.000957	CcSEcCtD
Cefpodoxime—Somnolence—Methotrexate—germ cell cancer	0.000954	0.000954	CcSEcCtD
Cefpodoxime—Dyspepsia—Methotrexate—germ cell cancer	0.000945	0.000945	CcSEcCtD
Cefpodoxime—Decreased appetite—Methotrexate—germ cell cancer	0.000933	0.000933	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000927	0.000927	CcSEcCtD
Cefpodoxime—Fatigue—Methotrexate—germ cell cancer	0.000926	0.000926	CcSEcCtD
Cefpodoxime—Pain—Methotrexate—germ cell cancer	0.000918	0.000918	CcSEcCtD
Cefpodoxime—Feeling abnormal—Methotrexate—germ cell cancer	0.000885	0.000885	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000878	0.000878	CcSEcCtD
Cefpodoxime—Urticaria—Methotrexate—germ cell cancer	0.000853	0.000853	CcSEcCtD
Cefpodoxime—Abdominal pain—Methotrexate—germ cell cancer	0.000849	0.000849	CcSEcCtD
Cefpodoxime—Body temperature increased—Methotrexate—germ cell cancer	0.000849	0.000849	CcSEcCtD
Cefpodoxime—Hypersensitivity—Methotrexate—germ cell cancer	0.000791	0.000791	CcSEcCtD
Cefpodoxime—Asthenia—Methotrexate—germ cell cancer	0.00077	0.00077	CcSEcCtD
Cefpodoxime—Pruritus—Methotrexate—germ cell cancer	0.000759	0.000759	CcSEcCtD
Cefpodoxime—Diarrhoea—Methotrexate—germ cell cancer	0.000734	0.000734	CcSEcCtD
Cefpodoxime—Dizziness—Methotrexate—germ cell cancer	0.00071	0.00071	CcSEcCtD
Cefpodoxime—Vomiting—Methotrexate—germ cell cancer	0.000683	0.000683	CcSEcCtD
Cefpodoxime—Rash—Methotrexate—germ cell cancer	0.000677	0.000677	CcSEcCtD
Cefpodoxime—Dermatitis—Methotrexate—germ cell cancer	0.000676	0.000676	CcSEcCtD
Cefpodoxime—Headache—Methotrexate—germ cell cancer	0.000673	0.000673	CcSEcCtD
Cefpodoxime—Nausea—Methotrexate—germ cell cancer	0.000638	0.000638	CcSEcCtD
